PDE9A-TMPRSS2 Fusion FISH Probe
The PDE9A-TMPRSS2 Fusion FISH Probe is used to confirm a fusion of the PDE9A and TMPRSS2 genes. The fusion of the PDE9A and TMPRSS2 genes has been associated with Prostate Adenocarcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| PDE9A-TMPRSS2-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| PDE9A-TMPRSS2-20-RERE | 20 (40 μL) | 200 μL |
|
|
| PDE9A-TMPRSS2-20-REOR | 20 (40 μL) | 200 μL |
|
|
| PDE9A-TMPRSS2-20-REGO | 20 (40 μL) | 200 μL |
|
|
| PDE9A-TMPRSS2-20-REGR | 20 (40 μL) | 200 μL |
|
|
| PDE9A-TMPRSS2-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| PDE9A-TMPRSS2-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| PDE9A-TMPRSS2-20-OROR | 20 (40 μL) | 200 μL |
|
|
| PDE9A-TMPRSS2-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| PDE9A-TMPRSS2-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| PDE9A-TMPRSS2-20-GORE | 20 (40 μL) | 200 μL |
|
|
| PDE9A-TMPRSS2-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| PDE9A-TMPRSS2-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| PDE9A-TMPRSS2-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| PDE9A-TMPRSS2-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| PDE9A-TMPRSS2-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| PDE9A-TMPRSS2-20-GROR | 20 (40 μL) | 200 μL |
|
|
| PDE9A-TMPRSS2-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| PDE9A-TMPRSS2-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| PDE9A-TMPRSS2-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| PDE9A-TMPRSS2-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| PDE9A-TMPRSS2-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| PDE9A-TMPRSS2-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| PDE9A-TMPRSS2-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| PDE9A-TMPRSS2-20-AQAQ | 20 (40 μL) | 200 μL |
|
PDE9A Gene Summary
The protein encoded by this gene catalyzes the hydrolysis of cAMP and cGMP to their corresponding monophosphates. The encoded protein plays a role in signal transduction by regulating the intracellular concentration of these cyclic nucleotides. Multiple transcript variants encoding several different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
Gene Name: Phosphodiesterase 9A
Chromosome: CHR21: 44073861 -44195618
Locus: 21q22.3
TMPRSS2 Gene Summary
This gene encodes a protein that belongs to the serine protease family. The encoded protein contains a type II transmembrane domain, a receptor class A domain, a scavenger receptor cysteine-rich domain and a protease domain. Serine proteases are known to be involved in many physiological and pathological processes. This gene was demonstrated to be up-regulated by androgenic hormones in prostate cancer cells and down-regulated in androgen-independent prostate cancer tissue. The protease domain of this protein is thought to be cleaved and secreted into cell media after autocleavage. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2008]
Gene Name: Transmembrane Protease, Serine 2
Chromosome: CHR21: 42836477 -42880085
Locus: 21q22.3
Gene Diseases
The PDE9A TMPRSS2 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Prostate Adenocarcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|